These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27727306)

  • 1. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
    Friciu M; Zaraa S; Roullin VG; Leclair G
    PLoS One; 2016; 11(10):e0164577. PubMed ID: 27727306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
    Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
    Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
    Jarouche M; Ibrahim M; Pearson J; Low M; Rowe J
    Int J Pharm Compd; 2020; 24(1):77-82. PubMed ID: 32023219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
    Coache D; Friciu M; Bernine Marcellin R; Bonnemain L; Viau A; Roullin VG; Forest JM; Leclair G
    PLoS One; 2022; 17(6):e0270206. PubMed ID: 35749410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes.
    St-Jean I; Friciu MM; Monfort A; MacMahon J; Forest JM; Walker S; Leclair G
    Can J Hosp Pharm; 2021; 74(4):327-333. PubMed ID: 34602620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
    Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.